gms | German Medical Science

Jahrestagung der Vereinigung Westdeutscher Hals-Nasen-Ohren-Ärzte 2024

08.03. - 09.03.2024, Köln

Advanced Stratification in Oropharyngeal Cancer: Benchmarking AI-driven HPV Association Analysis Against Established p16 Staining and HPV-DNA Techniques

Meeting Abstract

Suche in Medline nach

Vereinigung Westdeutscher HNO-Ärzte. Jahrestagung der Vereinigung Westdeutscher Hals-Nasen-Ohren-Ärzte. Köln, 08.-09.03.2024. Düsseldorf: German Medical Science GMS Publishing House; 2024. Doc30

doi: 10.3205/24wdhno30, urn:nbn:de:0183-24wdhno300

Veröffentlicht: 9. Februar 2024

© 2024 Kopp et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Introduction: The management of Oropharyngeal Squamous Cell Carcinomas (OPSCC) significantly benefits from improved stratification methods, especially considering the pivotal role of Human Papillomavirus (HPV) association in prognosticating disease course. Traditional methods, including p16 immunohistochemistry and HPV DNA detection, may not fully capture tumor heterogeneities and patient subpopulations.

Methods: In this retrospective, multi-institutional study of 906 patients, we developed OPSCCnet, a Deep Learning (DL) algorithm to analyze standard Hematoxylin and Eosin (H&E) stained slides. Our methodology utilizes a Feature Pyramid Network with a ResNet-18 encoder for semantic segmentation of tumor areas and HPV association classification.

Results OPSCCnet demonstrated a mean area under the receiver operator curve (AUROC) of 0.83 for the test cohort, which improved to 0.88 with a variance threshold for HPV-positive class probability. In prognostication, OPSCCnet showed a superior five-year survival rate prediction (96% [95% CI = 90–100%]) compared to standard HPV testing (80% [95% CI = 71–90%]). The three-tier threshold analysis using OPSCCnet indicated a high hazard ratio (HR = 0.15 [95% CI = 0.05–0.44]) in multivariate analysis, outperforming HPV testing (HR = 0.29 [95% CI = 0.15–0.54]).

Discussion: OPSCCnet, by analyzing standard H&E histological slides, outperforms traditional p16/HPV-DNA testing in patient stratification and survival prediction in OPSCC. These findings underscore the potential of AI-driven methodologies in enhancing patient stratification and advancing personalized medicine in oncologic care.